drugset / Trial / NCT04867057
Trichomylin® Safety, Tolerability & Pharmacokinetics in Healthy Adults and First in Human Osteoarthritis Pain Evaluation
Phase 1
Completed
41 enrolled
ZYUS Life Sciences Inc.
Novotech (Australia) Pty Limited · collabZYUS Life Sciences Australia Pty Ltd · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a first in human, randomized, double-blind, placebo-controlled SAD (with food effect) followed by a MAD study of Trichomylin® conducted in healthy adult participants.
Timeline
- Start
- 2021-04-19
- Primary completion
- 2022-02-18
- Completion
- 2022-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trichomylin | Unknown | — | Oral |